Advisory Board

Leah Cann, Founder, Leah Rush Cann Research and Consulting, LLC, and Founder and Chairman, Board of Hope Funds for Cancer Research
Leah is an independent research analyst in Newport, RI. She began her career as a research scientist with Memtec Corporation and moved to Wall Street in 1992, where she was a research analyst with CIBC Oppenheimer for nearly nine years. Leah was a heath care analyst for Cadence Capital and Wachovia Securities. Twice recognized as an All-Star analyst by the Wall Street Journal, she is the founder of Leah Rush Cann Research and Consulting, LLC, a Newport, Rhode Island-based cancer research and consulting organization.

Roy Vagelos M.D., Chair of the Columbia University School of Physicians and Surgeons Development Campaign and of the board of directors of Regeneron Pharmaceuticals
Former CEO, Chairman and Senior Vice President for Research of Merck.  Former chairman of the Department of Biological Chemistry and Director of the University’s Division of Biology and Biomedical Sciences at Washington University’s School of Medicine, St Louis, MO. Former Senior Surgeon and then Section Head of Comparative Biochemistry at the National Institutes of Health in Bethesda, MD. Dr. Vagelos holds a BS in Chemistry from the University of Pennsylvania and a M.D. from Columbia School of Medicine.